Search results
US FDA approves Bristol Myers' colorectal cancer therapy
Colorado Springs Gazette· 1 day agoAbout 34% of the patients who were given the combination treatment showed a partial or complete...
FDA Expands Pembrolizumab Approval for Endometrial Cancer
Medscape· 5 days agoThe FDA expanded the approval of pembrolizumab based on improved PFS in patients with advanced or...
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers | Texarkana Gazette
Texarkana Gazette· 1 day agoThe FDA said it authorized four menthol e-cigarettes from Njoy, the vaping brand recently acquired by tobacco giant Altria, which also...longstanding claim that their products ...
FDA places partial clinical hold on Zentalis’ trials of azenosertib for cancer
Clinical Trials Arena via Yahoo Finance· 4 days ago“We have completed enrolment for Cohort Ib of the DENALI study, where we have enrolled more than 100...
FDA approves menthol vapes, drawing criticism from health advocates
Washington Post· 1 day agoThe Food and Drug Administration on Friday approved the first menthol-flavored e-cigarette products,...
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 6 days agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
Could an FDA-approved cancer drug help stop Parkinson's disease progression?
MedicalNewsToday via AOL· 23 hours agoAn existing cancer drug has shown promise in halting Parkinson's disease progression in mouse...
FDA sign-off on menthol e-cigarettes ‘flies in the face of public health,’ anti-tobacco groups say
KOMU Columbia· 9 hours agoThe decision drew harsh criticism from pediatricians and anti-tobacco groups, which called it “a blow to public health” and warned of potential for “disastrous consequences” to children. Friday ...
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
Zacks via Yahoo Finance· 4 days agoZentalis' (ZNTL) three studies evaluating azenosertib for three different cancer indications face...
FDA approves MSD’s KEYTRUDA for advanced endometrial cancer
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe latest development comes after MSD signed a definitive agreement to acquire all outstanding...